+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo



Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo



Journal of Immunology 139(9): 3153-3158



We have induced fresh peripheral blood K/natural killer cells to lyse a variety of target cells by coating them with anti-Fc gamma receptor (anti-Fc gamma R) (CD16) antibody hetero-cross-linked with anti-target cell antibody. The cytotoxic cell mediating this activity is different, as judged by depletion studies, from the CD3+, CD8+ T cell which is targeted by anti-CD3 cross-linked to anti-target cell antibody. Targeted K cell activity from some donors is enhanced by exposure to interleukin 2 but not interferon-gamma; other donors exhibit high amounts of this activity without stimulation. Specificity of lysis mediated by targeted K cells is dictated by the specificity of the anti-target cell antibody within the heteroconjugate, and bystander cells are not lysed by targeted K cells. Hetero-cross-linked antibodies containing anti-histocompatibility leukocyte antigen class I instead of anti-Fc gamma R (CD16) do not promote lysis, suggesting that the bridging of the target cell to Fc gamma R on the K cell is required to activate the lytic process. Lysis mediated by targeted K cells is much less inhibitable by polymerized IgG than is classical antibody-dependent cellular cytotoxicity. Fresh human melanoma cells are lysed specifically by K cells coated with anti-Fc gamma R (CD16) cross-linked to the 96.5 anti-melanoma antibody. In vivo, targeted K cells prevent tumor growth at low effector to target ratios in Winn-type tumor neutralization assays. Targeted K cells may therefore provide a new immunotherapeutic approach for the destruction of detrimental cells, such as tumor and virally infected cells.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040310095

Download citation: RISBibTeXText

PMID: 2959724


Related references

Human t cells targeted with hetero cross linked antibodies prevent tumor growth in nude mice. Battisto, J R , J Plate And G Shearer (Ed ) Annals Of The New York Academy Of Sciences, Vol 532 Cytotoxic T Cells: Biology And Relevance to Disease; Conference, Bethesda, Maryland, Usa, May 13-15, 1987 Xiv+489p New York Academy Of Sciences: New York, New York, Usa Illus 465-467, 1988

Lymphokine activated killer cells targeted by monoclonal antibodies to the disialogangliosides gd 2 amd gd 3 specifically lyse human tumor cells of neuroectodermal origin. Proceedings of the National Academy of Sciences of the United States of America 83(20): 7893-7897, 1986

Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice. Journal of Immunology 138(11): 4018-4022, 1987

Tumor-primed human natural killer cells lyse NK-resistant tumor targets: Evidence of a two-stage process in resting NK cell activation. Journal of Immunology 178(1): 85-94, 2007

Human natural killer cells require both calcium and magnesium to lyse either hsv 1 infected fibroblasts or k562 tumor cells. FASEB Journal 6(4): A1216, 1992

Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo. Journal of Experimental Medicine 149(5): 1260-1264, 1979

Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets. European Journal of Immunology 31(9): 2818-2828, 2001

Natural killer cells require calcium and PKC activation to lyse both HSV-1-infected fibroblasts and K562 tumor cells. Natural Immunity 11(5): 246, 1992

In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor. Journal of Interferon Research 7(6): 821, 1987

In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor. Cancer Immunology ImmunoTherapy 27(2): 128-132, 1988

The opposite effect of tumor-infiltrating natural killer cells on in vivo priming of tumor-specific CD8+ T cells and CD4+ T cells. Immunobiology 195(2): 172-186, 1996

Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells. American Journal of Hematology 86(12): 967-973, 2011

Anti-tumor monoclonal antibodies enhance cross presentation of cellular antigens and generation of tumor specific killer cells by dendritic cells. Blood 98(11 Part 2): 33b, 2001

Genetically determined capacity of natural killer cells to lyse tumor targets. FASEB Journal 10(6): A1187, 1996

Heterogeneity of human natural killer effector cells which lyse herpes simplex virus type 1 infected fibroblasts are related to but distinct from those which lyse k 562 cells. Immunobiology-4: 403-404, 1982